Zevalin

Active Ingredient(s): Ibritumomab Tiuxetan
FDA Approved: * February 19, 2002
Pharm Company: * IDEC PHARMACEUTICALS CORP
Category: Cancer

Ibritumomab tiuxetan (pronounced /brtumomæb takstæn/[1]), sold under the trade name Zevalin, is a monoclonal antibody radioimmunotherapy treatment for non-Hodgkin's lymphoma. The drug uses the monoclonal mouse IgG1 antibody ibritumomab in conjunction with the chelator tiuxetan, to which a radioactive isotope (either yttrium-90 or indium-111) is added. Tiuxetan is a modified version of DTPA whose carbon backbone contains an isothiocyanatobenzyl and a methyl group.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Zevalin Kit
NDC: 68152-103
Labeler:
Spectrum Pharmaceuticals, Inc.
ZevalinZevalin Kit
NDC: 72893-007
Labeler:
Acrotech Biopharma LLC

Popular Topics

Zevalin Treatment Questions

I need to speak with people that did this treatment. ## My husband recently had this treatment -- I too had a hard time ...

2 REPLIES